THDB(SH:600867)2021-10-27 16:00Financial Performance - The company's operating revenue for Q3 2021 was ¥792,721,687.65, representing an increase of 11.52% compared to the same period last year[4]. - The net profit attributable to shareholders for Q3 2021 was ¥393,760,995.68, showing a significant increase of 83.72% year-on-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥245,514,194.92, up by 17.17% from the previous year[4]. - Total operating revenue for the first three quarters of 2021 reached ¥2,455,020,870.24, an increase from ¥2,185,625,572.14 in the same period of 2020, representing a growth of approximately 12.3%[18]. - Net profit for the third quarter of 2021 was ¥1,067,711,602.26, compared to ¥753,236,525.59 in the third quarter of 2020, reflecting a year-over-year increase of about 41.7%[19]. - Operating profit for the third quarter of 2021 was ¥1,259,768,211.82, up from ¥899,188,088.95 in the same quarter of 2020, indicating a growth of approximately 40%[19]. - Basic earnings per share for Q3 2021 were ¥0.52, up from ¥0.37 in Q3 2020, representing a growth of about 40.5%[20]. Assets and Liabilities - The total assets at the end of the reporting period reached ¥6,307,934,587.29, an increase of 8.70% compared to the end of the previous year[5]. - The company's total equity attributable to shareholders was ¥5,979,221,249.25, reflecting a year-on-year increase of 7.66%[5]. - The total liabilities as of September 30, 2021, were RMB 288,527,696.32, compared to RMB 208,182,680.98 at the end of 2020, indicating an increase of approximately 38.6%[16]. - The company's total liabilities increased to ¥323,140,212.08 in Q3 2021 from ¥243,801,452.51 in Q3 2020, marking an increase of about 32.6%[18]. - The total cash and cash equivalents at the end of the period reached CNY 500,072,668.72, up from CNY 267,326,470.10 at the end of the previous year, representing an increase of approximately 87.00%[22]. Cash Flow - The company reported a net cash flow from operating activities of ¥803,693,592.46 for the year-to-date, reflecting a decrease of 5.36% compared to the previous year[5]. - The cash inflow from operating activities for the first three quarters of 2021 was CNY 2,335,164,106.97, an increase from CNY 2,066,756,404.42 in the same period of 2020, representing a growth of approximately 12.97%[21]. - The net cash flow from operating activities decreased to CNY 803,693,592.46 in 2021 from CNY 849,219,226.94 in 2020, reflecting a decline of about 5.36%[21]. - Cash inflow from investment activities significantly increased to CNY 1,093,612,737.31 in 2021, compared to CNY 263,296,122.56 in 2020, marking a growth of approximately 315.56%[22]. - The net cash flow from investment activities improved to -CNY 91,831,570.07 in 2021 from -CNY 339,561,045.03 in 2020, indicating a reduction in losses[22]. - The net cash flow from financing activities was -CNY 603,821,257.47 in 2021, compared to -CNY 539,468,582.68 in 2020, indicating a worsening in financing cash flow[22]. Research and Development - Research and development expenses increased by 44.17% year-on-year due to new projects and increased investment in R&D[7]. - Research and development expenses for the first three quarters of 2021 amounted to ¥118,279,877.05, compared to ¥82,041,684.47 in the same period of 2020, indicating an increase of approximately 44%[18]. Investment and Equity Transactions - The company disposed of part of its equity in Te Bao Bio, resulting in an investment income increase of 514.69%[7]. - The company reported investment income of ¥223,870,818.37 for the first three quarters of 2021, significantly higher than ¥36,419,982.61 in the same period of 2020, showing an increase of approximately 515%[18]. - The company repurchased a total of 11,999,766 shares, accounting for 0.59% of the total share capital, with a total transaction amount of RMB 129,175,483.58[12]. - Tonghua Dongbao plans to sell up to 16,272,000 shares of Xiamen Te Bao Biological Engineering Co., Ltd., which is not more than 4% of Te Bao's total share capital[12].